BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8318410)

  • 1. Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.
    Miller BE; Miller FR; Machemer T; Heppner GH
    Br J Cancer; 1993 Jul; 68(1):18-25. PubMed ID: 8318410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis.
    Aslakson CJ; Rak JW; Miller BE; Miller FR
    Int J Cancer; 1991 Feb; 47(3):466-72. PubMed ID: 1993557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors.
    Miller BE; Machemer T; Lehotan M; Heppner GH
    Cancer Res; 1991 Aug; 51(16):4378-87. PubMed ID: 1868461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines.
    Miller BE; Miller FR; Wilburn DJ; Heppner GH
    Br J Cancer; 1987 Nov; 56(5):561-9. PubMed ID: 3426919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal variation in the sensitivity of a murine mammary carcinoma to melphalan.
    McMillan TJ; Stephens TC; Steel GG
    Br J Cancer; 1986 Jun; 53(6):753-9. PubMed ID: 3718828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1985 Sep; 45(9):4200-5. PubMed ID: 4028010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites.
    Unemori EN; Ways N; Pitelka DR
    Br J Cancer; 1984 May; 49(5):603-14. PubMed ID: 6722008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
    Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
    Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed inocula of mouse mammary tumour cell subpopulations result in changes of organ-specific metastasis.
    Hossain A; Sarkar A; Sarkar NH
    Clin Exp Metastasis; 1991; 9(6):501-15. PubMed ID: 1752081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.
    Rak JW; McEachern D; Miller FR
    Br J Cancer; 1992 May; 65(5):641-8. PubMed ID: 1586590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of metastatic cell lines derived from a murine mammary tumour, and reduction of metastasis by heparin.
    Lee AE; Rogers LA; Jeffery RE; Longcroft JM
    Clin Exp Metastasis; 1988; 6(6):463-71. PubMed ID: 3409560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor subpopulation interactions in metastasis.
    Miller FR
    Invasion Metastasis; 1983; 3(4):234-42. PubMed ID: 6677628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
    Tofilon PJ; Basic I; Milas L
    Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay.
    Thompson SC
    Br J Cancer; 1974 Oct; 30(4):332-6. PubMed ID: 4141261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants.
    Holden SA; Emi Y; Kakeji Y; Northey D; Teicher BA
    Cancer Chemother Pharmacol; 1997; 40(1):87-93. PubMed ID: 9137536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous fusion between metastatic mammary tumor subpopulations.
    Miller FR; McInerney D; Rogers C; Miller BE
    J Cell Biochem; 1988 Feb; 36(2):129-36. PubMed ID: 3356752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1989 Jul; 49(14):3747-53. PubMed ID: 2736515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Wilburn D; Heppner GH
    Cancer Res; 1988 Oct; 48(20):5747-53. PubMed ID: 3167832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
    Di Carlo E; Modesti A; Castrilli G; Landuzzi L; Allione A; de Giovanni C; Musso T; Musiani P
    J Pathol; 1997 May; 182(1):76-85. PubMed ID: 9227345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.